无比对k-mer引导的泛正黄病毒属RT-qPCR assay设计
研究开发了一种基于无比对k-mer分析和紧凑De Bruijn图的系统设计流程,分析11,846个RefSeq病毒基因组,识别正黄病毒属内保守的600 bp NS5基因区域,设计广谱TaqMan RT-qPCR assay。分析验证显示DENV1-4、ZIKV、JEV和YFV的LOD为1-10 copies/µL,无交叉反应;WNV在试点实验中于1,000 copies/µL一致检出。临床评估 archived samples 总体准确率97.33%,DENV血清型100%灵敏度和特异性,ZIKV特异性100%但灵敏度71.43%。
要点
- 该assay对DENV1-4、ZIKV、JEV和YFV的LOD为1-10 copies/µL。
- 临床评估总体准确率97.33%,DENV血清型灵敏度和特异性均100%。
- ZIKV检测特异性100%,灵敏度71.43%。
核心结论
- 无比对k-mer引导策略可揭示高度变异病毒属中的保守诊断靶标,并成功设计广谱RT-qPCR assay。
研究设计与样本
- 基于11,846个RefSeq病毒基因组,采用k-mer分析和紧凑De Bruijn图的无比对设计流程,后续局部MSA辅助引物探针设计。
主要发现
- 识别正黄病毒属非结构蛋白5基因内保守600 bp区域用于assay设计。
- 分析验证LOD为1-10 copies/µL(DENV1-4、ZIKV、JEV、YFV),无交叉反应;WNV在试点实验中于1,000 copies/µL一致检出。
- 临床评估 archived samples 总体准确率97.33%,DENV血清型灵敏度和特异性100%,ZIKV特异性100%、灵敏度71.43%。
关键数值与推荐
- LOD:1-10 copies/µL(DENV1-4、ZIKV、JEV、YFV);WNV在1,000 copies/µL试点实验中一致检出。
- 临床评估总体准确率97.33%;DENV血清型灵敏度100%、特异性100%;ZIKV特异性100%、灵敏度71.43%。
临床怎么用
- 该assay可用于前线广谱监测多种蚊媒正黄病毒,计算框架可扩展用于未来大流行准备。
局限性
- WNV仅在试点实验中以1,000 copies/µL检出,未报告更低浓度LOD。
- ZIKV临床灵敏度为71.43%,低于DENV血清型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The co-circulation and rapid expansion of the genus Orthoflavivirus, including dengue virus (DENV), Zika virus (ZIKV), West Nile virus (WNV), Yellow fever virus (YFV), and Japanese encephalitis virus (JEV), pose significant global health challenges. Developing inclusive pan-genus molecular diagnostics is hindered by high nucleotide divergence (>25-30%) and the computational limitations of traditional multiple sequence alignment in detecting conserved motifs across large data sets. To overcome these limitations, we developed a systematic alignment-free design pipeline that uses rigorous k-mer analysis and compacted De Bruijn graphs. We analyzed 11,846 RefSeq viral genomes to identify phylogenetically conserved, functionally relevant signatures within the Orthoflavivirus genus as a case study. The pipeline identified a conserved 600 bp region within the non-structural protein 5 gene, facilitating the design of a broad-spectrum TaqMan RT-qPCR assay. Analytical validation demonstrated limits of detection (LODs) of 1-10 copies/µL for DENV1-4, ZIKV, JEV, and YFV, with no cross-reactivity against non-target pathogens; WNV was consistently detected at 1,000 copies/µL in pilot experiments. In a clinical evaluation of archived samples, the assay achieved 97.33% overall accuracy. It demonstrated 100% sensitivity and specificity for DENV serotypes, yielding significantly earlier cycle threshold (Ct) values compared to a standard commercial kit, while ZIKV detection showed 100% specificity with 71.43% sensitivity. This study validates an alignment-free, k-mer-guided strategy for uncovering conserved diagnostic targets in highly variable viral genera, followed by local MSA-assisted primer-probe design. The resulting assay offers a robust tool for broad frontline surveillance, and the computational framework provides a scalable solution for future pandemic preparedness.IMPORTANCEMosquito-borne viruses like dengue, Zika, and West Nile pose a massive threat to global health. However, because these viruses are highly diverse and mutate rapidly, creating a single diagnostic test to detect all of them has been a challenge. Traditional software struggles to find shared genetic targets across such different viruses. To solve this, we developed a new computational approach. By analyzing over 11,000 viral genomes, we successfully identified a shared genetic signature of a group of mosquito-borne viruses. We used this discovery to create a single, highly accurate test capable of detecting multiple dangerous mosquito-borne viruses at once. This breakthrough provides a crucial, ready-to-use tool for frontline clinical diagnosis and global outbreak surveillance. More importantly, our strategy can be quickly adapted to design broad-spectrum tests for other rapidly mutating viruses, significantly strengthening our ability to prepare for and respond to future pandemics.
引用
- Sayasit K, Chaimayo C, Nuwong W, et al. Alignment-free k-mer-guided design of a pan-Orthoflavivirus RT-qPCR assay. J Clin Microbiol. 2026. PMID: 42506928. doi:10.1128/jcm.00388-26
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。